enow.com Web Search

  1. Ads

    related to: symptoms of relapsing remitting ms treatment guidelines
  2. wexnermedical.osu.edu has been visited by 10K+ users in the past month

    262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464

Search results

  1. Results from the WOW.Com Content Network
  2. Management of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Management_of_multiple...

    In March 2020, ozanimod (Zeposia) was approved in the United States for the treatment of relapsing multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. [9] [52] [53] [54]

  3. Signs and symptoms of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Signs_and_symptoms_of...

    Main symptoms of multiple sclerosis Symptoms and findings in multiple sclerosis. Multiple sclerosis can cause a variety of symptoms varying significantly in severity and progression among individuals: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech or swallowing (), visual ...

  4. Relapsing–remitting - Wikipedia

    en.wikipedia.org/wiki/Relapsingremitting

    The term is used to describe a type of multiple sclerosis called relapsingremitting multiple sclerosis, where unpredictable relapses are followed by remission for months to years. [ 1 ] The term is also used to describe palindromic rheumatism in the context of rheumatoid arthritis , [ 2 ] catatonia , [ 3 ] [ 4 ] lupus , [ 5 ] mental ...

  5. Multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Multiple_sclerosis

    It is also used for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. [156]

  6. Ocrelizumab - Wikipedia

    en.wikipedia.org/wiki/Ocrelizumab

    In February 2016, the US Food and Drug Administration (FDA) granted breakthrough therapy designation for primary progressive multiple sclerosis. [21] In March 2017, the FDA approved ocrelizumab for relapsing-remitting and primary-progressive multiple sclerosis. It is the first FDA-approved treatment for the primary progressive form.

  7. Interferon beta-1a - Wikipedia

    en.wikipedia.org/wiki/Interferon_beta-1a

    The earliest clinical presentation of relapsing-remitting multiple sclerosis is the clinically isolated syndrome (CIS), that is, a single attack of a single symptom. During a CIS, there is a subacute attack suggestive of demyelination which should be included in the spectrum of MS phenotypes. [ 13 ]

  8. McDonald criteria - Wikipedia

    en.wikipedia.org/wiki/McDonald_criteria

    Some of these people will develop MS even after several years. Because early initiation of MS disease-modifying therapy is associated with better clinical outcomes, it is important to identify individuals in the subclinical stage of disease and determine if initiation of treatment at this stage is beneficial.

  9. Pathophysiology of multiple sclerosis - Wikipedia

    en.wikipedia.org/wiki/Pathophysiology_of...

    There are three clinical phenotypes: relapsing-remitting MS (RRMS), characterized by periods of neurological worsening following by remissions; secondary-progressive MS (SPMS), in which there is gradual progression of neurological dysfunction with fewer or no relapses; and primary-progressive MS (MS), in which neurological deterioration is ...

  1. Ads

    related to: symptoms of relapsing remitting ms treatment guidelines